Modifications of liver stiffness and CXCL4, TGF-β1 and HGF are similar in HCV- and HIV/HCV-infected patients after DAAs
Abstract The objective of this work was to identify predictive factors of fibrosis regression after direct antiviral agents (DAAs) in HCV-monoinfected and HIV/HCV-coinfected patients. This was a prospective study of HCV-monoinfected (n = 20), HIV/HCV-co-infected (n = 66) patients and healthy control...
Guardado en:
Autores principales: | Mercedes Márquez-Coello, Ana Arizcorreta, María Rodríguez-Pardo, Francisco Illanes-Álvarez, Denisse Márquez, Sara Cuesta-Sancho, José-Antonio Girón-González |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cfe9d9450e2a40d7a8bdb638aba668a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy
por: Stefania Farcomeni, et al.
Publicado: (2021) -
Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA
por: Atsushi Hosui, et al.
Publicado: (2021) -
CHALLENGES AND PERSPECTIVES IN HEPATITIS C VIRUS (HCV) RESEARCH IN AN ERA OF DIRECT ACTING ANTIVIRAL (DAA) THERAPY
por: A. Budkowska
Publicado: (2018) -
HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization
por: Daniel Valle-Millares, et al.
Publicado: (2022) -
Single-cell transcriptomic analyses of T cells in chronic HCV-infected patients dominated by DAA-induced interferon signaling changes.
por: Matthew A Burchill, et al.
Publicado: (2021)